Fundraising Fox
/Companies
Sign in

ImmuNovus

Denton, US · Founded 2022 · Delaware corporation

Find your way into ImmuNovus

Sign up to see every warm intro you have to ImmuNovus

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ImmuNovus team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Immunovus develops software that creates a personal immune "digital twin" to model and forecast an individual's immune trajectory, integrating and interpreting health data such as test results. It targets consumers, clinicians, and pharmaceutical companies, supporting scenario forecasting, personalized clinical trials, drug discovery, and drug repurposing.

AI & Machine LearningBiotechDigital Health

Founders & leadership

ImmuNovus was founded in 2022 by Tomas Helikar.

THTomas Helikar
Tomas HelikarFounder and CEO

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2026

▶$1MraisedJul 2026 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tomas HelikarExecutive Officer
Offering amount
$5M
Amount sold
$1M
Minimum investment
$10
First sale
Jul 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does ImmuNovus do?
Immunovus develops software that creates a personal immune "digital twin" to model and forecast an individual's immune trajectory, integrating and interpreting health data such as test results. It targets consumers, clinicians, and pharmaceutical companies, supporting scenario forecasting, personalized clinical trials, drug discovery, and drug repurposing.
Who founded ImmuNovus?
ImmuNovus was founded by Tomas Helikar in 2022.
How much funding has ImmuNovus raised?
ImmuNovus has disclosed $1M raised across 1 round.
Where is ImmuNovus headquartered?
ImmuNovus is headquartered in Denton, US.